News
An ICCT analysis of CO2 fleet emissions shows that the car industry currently exceeds the EU limit by nine per cent. However, ...
Asianet Newsable on MSN29m
Why Retail Investors Are Turning Sharply Bullish On Apellis PharmaceuticalsThe FDA approved Apellis’ drug Empaveli for two rare kidney diseases, following strong results from a Phase 3 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback